Emboline, an emerging medical device company, has raised $10 million in a Series B round to get its embolic protection technology on the market in Europe.
News & Features
Aiming to fill a skills gap, an orthopedic surgeon has developed a virtual training platform for surgeons and their teams.
ReviveMed has raised $1.5 million in a seed round and is riding the growing artificial intelligence wave in healthcare.
Ethicon’s principal materials engineer discusses the latest in exciting new medical materials and considers where the trends will take device makers and designers in the years ahead.
A product development expert provides insights and specific case examples of how voice-enabled smart speakers like the Amazon Echo and Google Home could disrupt the medical device industry, beginning as early as the R&D phase.
Sonde Health wants to borrow your voice to develop new ways of detecting mental and physical health problems, including depression. This is just one way machine intelligence is disrupting medtech.
Despite the rumblings made by looming competition in the surgical robotics space, Intuitive Surgical remains unbothered and delivers solid quarter earnings, beating Wall Street expectations.
A new wave of breast pump manufacturers is challenging industry leaders with smart, compact, user-friendly designs.
Global Kinetics Corporation's Personal KinetiGraph is being used in a patient study supported by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), Shake It Up Australia Foundation, and Parkinson’s Victoria, to gain better insight on Parkinson's disease symptoms.
We're conducting a survey to see what you'd like to see more of on MD+DI and at our associated live conferences. To say thanks for sharing your opinion, we'll enter you in a sweepstakes for a chance to win a $500 Amazon gift card.
Bristol-Myers Squibb has teamed up with Illumina to develop companion diagnostics for oncology immunotherapies.
Spry Health is offering a unique opportunity for academic researchers to leverage the wearable Loop System to further understand human health and chronic disease.
Boston Scientific is acquiring nVision Medical for $150 million plus up to an additional $125 million in milestones.